Rayno Life Science Movers: AMGN, EXAS, ILMN, PCYC etc.
Update 1/8/13 Blow-Off anticipating J.P.Morgan Conference? Breakthrough: IBB hit new highs above $230 today. Green screen with most large cap and mid caps. ALKS, BIIB among movers. XBI is also up 2%. Rayno Life Science stocks are in the bullish groove as investors move back to growth. As of...
Celgene (CELG) Down 5%-Take Profits
Celgene (CELG $162) is not on the Rayno biopharmaceutical focus list but it is a good candidate for hedging with a short position or profit taking. Goldman downgraded the stock today from Neutral to SELL . Also, the Wall Street Journal has an article in the Marketplace section about a royalty...
Biotech Stocks: Flat Near Highs Since December 23
Steady As She Goes The IBB ($226) remains steady in the $225 range in quiet trading through the holiday period. The XBI ($130.69) shows a similar trend near its 52 week high. Fidelity Select Biotech Fund (FBIOX ) is at its one year high of $182.50. As 2014 unfolds we will follow key trends in...
Sierra SnowBlog-Grim Precip Outlook for West Coast Update 1/24/14 PDO
Update 12 N 1/23/14 Accuweather is sticking their umbrellas out calling for rain in San Francisco on Feb 4-but today downgraded that forecast. Unisys gives us nothing for six days.Same for NOAA9mh.gif 720×729 pixels Sheckter offers Hope for early Feb as well: Mammoth Lakes Weather brought to...
Rayno Life Science Focus Stocks Part II-2013 Performance Diagnostics and Tools
New Products for Molecular and Companion Diagnostics Drive Growth Rayno Life Science Big Winners-ALR, CSII, ILMN,TMO A diversified life science portfolio must include clinical diagnostics and tools stocks because of the synergies between therapy and diagnostics. Breakthroughs in molecular...